BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 333030)

  • 1. Immunochemical determination of ganglioside GM2, by inhibition of complement-dependent liposome lysis.
    Geiger B; Smolarsky M
    J Immunol Methods; 1977; 17(1-2):7-19. PubMed ID: 333030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method to measure anti-glycolipid antibody by using complement-mediated immune lysis of fluorescent dye-trapped liposomes.
    Yasuda T; Naito Y; Tsumita T; Tadakuma T
    J Immunol Methods; 1981; 44(2):153-8. PubMed ID: 7024415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
    Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
    Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune lysis of lipid vesicles containing myelin basic protein or glycolipid antigens by multiple sclerosis and normal sera.
    Boggs JM; Samji N; Adamo SA
    J Neurol Sci; 1984; 66(2-3):339-48. PubMed ID: 6085112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anti-cerebroside sulfate antisera using a theoretical model to analyse liposome immune lysis data.
    Crook SJ; Stewart R; Boggs JM; Vistnes AI; Zalc B
    Mol Immunol; 1987 Nov; 24(11):1135-43. PubMed ID: 3696165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response of rabbits to nerve ending gangliosides. Analysis of antibody specificity by liposome lysis and lysis inhibition assays.
    Uemura K; Kitazawa N; Taketomi T
    J Neuroimmunol; 1985 Sep; 9(5):269-80. PubMed ID: 4019749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of high titer antisera against sialoglycosphingolipids and their characterization using sensitized liposome.
    Nagai Y; Osawa T
    Jpn J Exp Med; 1974 Oct; 44(5):451-64. PubMed ID: 4474499
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological specificity of the liposome lysis test for measurement of anti-ganglioside antibodies. A comparison with hemagglutination inhibition.
    Zemmour J; Portoukalian J; Doré JF
    J Immunol Methods; 1984 Feb; 66(2):331-40. PubMed ID: 6361155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisera against ganglioside GM2: immunochemical and immunohistological studies.
    Schwerer B; Lassmann H; Bernheimer H
    Neuropathol Appl Neurobiol; 1982; 8(3):217-26. PubMed ID: 6214725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides.
    Miyake M; Ito M; Hitomi S; Ikeda S; Taki T; Kurata M; Hino A; Miyake N; Kannagi R
    Cancer Res; 1988 Nov; 48(21):6154-60. PubMed ID: 3167861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.
    Livingston PO; Calves MJ; Natoli EJ
    J Immunol; 1987 Mar; 138(5):1524-9. PubMed ID: 3805726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement-dependent immune damage to liposomes containing gangliosides.
    Shichijo S; Toffano G; Alving CR
    J Immunol Methods; 1985 Dec; 85(1):53-63. PubMed ID: 4078313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease.
    Hoffman LM; Amsterdam D; Schneck L
    Brain Res; 1976 Jul; 111(1):109-17. PubMed ID: 953690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple fluorescent method to determine complement-mediated liposome immune lysis.
    Smolarsky M; Teitelbaum D; Sela M; Gitler C
    J Immunol Methods; 1977; 15(3):255-65. PubMed ID: 323363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
    Ho RJ; Huang L
    J Immunol; 1985 Jun; 134(6):4035-40. PubMed ID: 3886794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of ganglioside GD3 on the cell surface using liposome immune lysis assay.
    Kobayashi K; Watarai S; Yasuda T
    Acta Med Okayama; 1992 Dec; 46(6):435-41. PubMed ID: 1485537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative responses of liposomes prepared with different ceramide antigens to antibody and complement.
    Inoue K; Kataoka T; Kinsky SC
    Biochemistry; 1971 Jun; 10(13):2574-81. PubMed ID: 5557803
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids.
    Wassef NM; Matyas GR; Alving CR
    Biochem Biophys Res Commun; 1991 Apr; 176(2):866-74. PubMed ID: 2025298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of membrane damage by complement: the effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes.
    Shin ML; Paznekas WA; Mayer MM
    J Immunol; 1978 Jun; 120(6):1996-2002. PubMed ID: 659889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.